CTRI/2019/02/017498尚未招募2 期
Efficacy of Habb -e- Shabyar in Hypertriglyceridemia associated with Metabolic Syndrome
ational Institute Of Unani MedicineNIUM0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age between 35-60 years
- •2.Patients of both the genders
- •3.Central Obesity: Waist Circumference > 90 cm in Male, >80 cm in Female
- •4.Hypertriglyceridemia: Triglycerides <499 mg/dl 5. Cases of hypertension with (Pre-hypertensive stage i.e. 120-139 systolic/80-89 diastolic)
- •6.Fasting Blood Glucose: 126 - < 200mg/dl
- •7.Postprandial Blood Glucose Level: >140 - <300 mg/dl
- •8.Patient not taking treatment for Hypertriglyceridemia (Statins)
排除标准
- •1.K/c/o Systemic diseases
- •2.Pregnant and Lactating women
- •3.Type-1 Diabetes
- •4.Patients on weight loss medication
- •5.Fasting Plasma Glucose >=200mg/dl
- •6.BP >=139/89 mmHg
- •7.Patients on treatment for Hypertriglyceridemia (Statins)
研究者
相似试验
已完成
4 期
The impact of pemafibrate on hypertriglyceridemia in patients with type 2 diabetes: A prospective cohort study.dyslipidemiJPRN-UMIN000037385Hokkaido University Hospital650
已完成
2 期
Efficacy of unani drug Itrifal-e-Sagheer in the treatment of obesity.CTRI/2017/09/009783Sazid Alam30
已完成
2 期
Treatment of Hyperlipedemia with Unani formulatioCTRI/2018/05/013864Central Council for Research in Unani Medicine60
尚未招募
2 期
Effect of Unani drug on DyslipidemiaCTRI/2020/09/027924ational Institute of Unani Medicine
招募中
不适用
The significance of Hypertriglyceridemia in life-style diseasesMetabolic syndrome, obesity, diabetes, hypertension, chronic kidney disease (CKD)JPRN-UMIN000037710Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Nephrology, Rheumatology, Endocrinology and Metabolism300